The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19
Eur Heart J Cardiovasc Pharmacother
.
2020 Jul 1;6(4):262-264.
doi: 10.1093/ehjcvp/pvaa048.
Authors
Mario Enrico Canonico
1
,
Roberta Siciliano
1
,
Fernando Scudiero
2
,
Giuseppe Damiano Sanna
1
,
Guido Parodi
1
Affiliations
1
Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.
2
Department of Cardiology, ASST Bergamo Est, Seriate, Italy.
PMID:
32383737
PMCID:
PMC7239225
DOI:
10.1093/ehjcvp/pvaa048
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Substances
Anticoagulants